Global Stereotactic-guided Biopsy Instrument Market Insights, Forecast to 2028

Publisher Name :
Date: 07-Apr-2022
No. of pages: 105
Inquire Before Buying

Stereotactic-guided Biopsy Instrument market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Stereotactic-guided Biopsy Instrument market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Needle-based Biopsy Instruments

- Localization Wires

- Procedure Trays

- Others

Segment by Application

- Breast Biopsy

- Lung Biopsy

- Colorectal Biopsy

- Prostate Biopsy

- Others

By Company

- C. R. Bard, Inc. (U.S.)

- Becton, Dickinson and Company (U.S.)

- Cook Group Incorporated (U.S.)

- Devicor Medical Products, Inc., (Leica Biosystems) (Germany)

- Argon Medical Devices (U.S.)

- B. Braun Melsungen AG (Germany)

- Cardinal Health, Inc. (U.S.)

- Olympus Corporation (Japan)

- Boston Scientific Corporation (U.S.)

- FUJIFILM Holdings Corporation (Japan)

- INRAD, Inc. (U.S.)

- Medtronic plc (Ireland)

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Global Stereotactic-guided Biopsy Instrument Market Insights, Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Stereotactic-guided Biopsy Instrument Product Introduction
1.2 Market by Type
1.2.1 Global Stereotactic-guided Biopsy Instrument Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Needle-based Biopsy Instruments
1.2.3 Localization Wires
1.2.4 Procedure Trays
1.2.5 Others
1.3 Market by Application
1.3.1 Global Stereotactic-guided Biopsy Instrument Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Breast Biopsy
1.3.3 Lung Biopsy
1.3.4 Colorectal Biopsy
1.3.5 Prostate Biopsy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Stereotactic-guided Biopsy Instrument Sales Estimates and Forecasts 2017-2028
2.2 Global Stereotactic-guided Biopsy Instrument Revenue Estimates and Forecasts 2017-2028
2.3 Global Stereotactic-guided Biopsy Instrument Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Stereotactic-guided Biopsy Instrument Sales by Region
2.4.1 Global Stereotactic-guided Biopsy Instrument Sales by Region (2017-2022)
2.4.2 Global Sales Stereotactic-guided Biopsy Instrument by Region (2023-2028)
2.5 Global Stereotactic-guided Biopsy Instrument Revenue by Region
2.5.1 Global Stereotactic-guided Biopsy Instrument Revenue by Region (2017-2022)
2.5.2 Global Stereotactic-guided Biopsy Instrument Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Stereotactic-guided Biopsy Instrument Sales by Manufacturers
3.1.1 Global Top Stereotactic-guided Biopsy Instrument Manufacturers by Sales (2017-2022)
3.1.2 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Stereotactic-guided Biopsy Instrument in 2021
3.2 Global Stereotactic-guided Biopsy Instrument Revenue by Manufacturers
3.2.1 Global Stereotactic-guided Biopsy Instrument Revenue by Manufacturers (2017-2022)
3.2.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Stereotactic-guided Biopsy Instrument Revenue in 2021
3.3 Global Stereotactic-guided Biopsy Instrument Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Stereotactic-guided Biopsy Instrument Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Stereotactic-guided Biopsy Instrument Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Stereotactic-guided Biopsy Instrument Sales by Type
4.1.1 Global Stereotactic-guided Biopsy Instrument Historical Sales by Type (2017-2022)
4.1.2 Global Stereotactic-guided Biopsy Instrument Forecasted Sales by Type (2023-2028)
4.1.3 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Type (2017-2028)
4.2 Global Stereotactic-guided Biopsy Instrument Revenue by Type
4.2.1 Global Stereotactic-guided Biopsy Instrument Historical Revenue by Type (2017-2022)
4.2.2 Global Stereotactic-guided Biopsy Instrument Forecasted Revenue by Type (2023-2028)
4.2.3 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Type (2017-2028)
4.3 Global Stereotactic-guided Biopsy Instrument Price by Type
4.3.1 Global Stereotactic-guided Biopsy Instrument Price by Type (2017-2022)
4.3.2 Global Stereotactic-guided Biopsy Instrument Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Stereotactic-guided Biopsy Instrument Sales by Application
5.1.1 Global Stereotactic-guided Biopsy Instrument Historical Sales by Application (2017-2022)
5.1.2 Global Stereotactic-guided Biopsy Instrument Forecasted Sales by Application (2023-2028)
5.1.3 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Application (2017-2028)
5.2 Global Stereotactic-guided Biopsy Instrument Revenue by Application
5.2.1 Global Stereotactic-guided Biopsy Instrument Historical Revenue by Application (2017-2022)
5.2.2 Global Stereotactic-guided Biopsy Instrument Forecasted Revenue by Application (2023-2028)
5.2.3 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Application (2017-2028)
5.3 Global Stereotactic-guided Biopsy Instrument Price by Application
5.3.1 Global Stereotactic-guided Biopsy Instrument Price by Application (2017-2022)
5.3.2 Global Stereotactic-guided Biopsy Instrument Price Forecast by Application (2023-2028)
6 North America
6.1 North America Stereotactic-guided Biopsy Instrument Market Size by Type
6.1.1 North America Stereotactic-guided Biopsy Instrument Sales by Type (2017-2028)
6.1.2 North America Stereotactic-guided Biopsy Instrument Revenue by Type (2017-2028)
6.2 North America Stereotactic-guided Biopsy Instrument Market Size by Application
6.2.1 North America Stereotactic-guided Biopsy Instrument Sales by Application (2017-2028)
6.2.2 North America Stereotactic-guided Biopsy Instrument Revenue by Application (2017-2028)
6.3 North America Stereotactic-guided Biopsy Instrument Market Size by Country
6.3.1 North America Stereotactic-guided Biopsy Instrument Sales by Country (2017-2028)
6.3.2 North America Stereotactic-guided Biopsy Instrument Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Stereotactic-guided Biopsy Instrument Market Size by Type
7.1.1 Europe Stereotactic-guided Biopsy Instrument Sales by Type (2017-2028)
7.1.2 Europe Stereotactic-guided Biopsy Instrument Revenue by Type (2017-2028)
7.2 Europe Stereotactic-guided Biopsy Instrument Market Size by Application
7.2.1 Europe Stereotactic-guided Biopsy Instrument Sales by Application (2017-2028)
7.2.2 Europe Stereotactic-guided Biopsy Instrument Revenue by Application (2017-2028)
7.3 Europe Stereotactic-guided Biopsy Instrument Market Size by Country
7.3.1 Europe Stereotactic-guided Biopsy Instrument Sales by Country (2017-2028)
7.3.2 Europe Stereotactic-guided Biopsy Instrument Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Stereotactic-guided Biopsy Instrument Market Size by Type
8.1.1 Asia Pacific Stereotactic-guided Biopsy Instrument Sales by Type (2017-2028)
8.1.2 Asia Pacific Stereotactic-guided Biopsy Instrument Revenue by Type (2017-2028)
8.2 Asia Pacific Stereotactic-guided Biopsy Instrument Market Size by Application
8.2.1 Asia Pacific Stereotactic-guided Biopsy Instrument Sales by Application (2017-2028)
8.2.2 Asia Pacific Stereotactic-guided Biopsy Instrument Revenue by Application (2017-2028)
8.3 Asia Pacific Stereotactic-guided Biopsy Instrument Market Size by Region
8.3.1 Asia Pacific Stereotactic-guided Biopsy Instrument Sales by Region (2017-2028)
8.3.2 Asia Pacific Stereotactic-guided Biopsy Instrument Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Stereotactic-guided Biopsy Instrument Market Size by Type
9.1.1 Latin America Stereotactic-guided Biopsy Instrument Sales by Type (2017-2028)
9.1.2 Latin America Stereotactic-guided Biopsy Instrument Revenue by Type (2017-2028)
9.2 Latin America Stereotactic-guided Biopsy Instrument Market Size by Application
9.2.1 Latin America Stereotactic-guided Biopsy Instrument Sales by Application (2017-2028)
9.2.2 Latin America Stereotactic-guided Biopsy Instrument Revenue by Application (2017-2028)
9.3 Latin America Stereotactic-guided Biopsy Instrument Market Size by Country
9.3.1 Latin America Stereotactic-guided Biopsy Instrument Sales by Country (2017-2028)
9.3.2 Latin America Stereotactic-guided Biopsy Instrument Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Stereotactic-guided Biopsy Instrument Market Size by Type
10.1.1 Middle East and Africa Stereotactic-guided Biopsy Instrument Sales by Type (2017-2028)
10.1.2 Middle East and Africa Stereotactic-guided Biopsy Instrument Revenue by Type (2017-2028)
10.2 Middle East and Africa Stereotactic-guided Biopsy Instrument Market Size by Application
10.2.1 Middle East and Africa Stereotactic-guided Biopsy Instrument Sales by Application (2017-2028)
10.2.2 Middle East and Africa Stereotactic-guided Biopsy Instrument Revenue by Application (2017-2028)
10.3 Middle East and Africa Stereotactic-guided Biopsy Instrument Market Size by Country
10.3.1 Middle East and Africa Stereotactic-guided Biopsy Instrument Sales by Country (2017-2028)
10.3.2 Middle East and Africa Stereotactic-guided Biopsy Instrument Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 C. R. Bard, Inc. (U.S.)
11.1.1 C. R. Bard, Inc. (U.S.) Corporation Information
11.1.2 C. R. Bard, Inc. (U.S.) Overview
11.1.3 C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 C. R. Bard, Inc. (U.S.) Recent Developments
11.2 Becton, Dickinson and Company (U.S.)
11.2.1 Becton, Dickinson and Company (U.S.) Corporation Information
11.2.2 Becton, Dickinson and Company (U.S.) Overview
11.2.3 Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Becton, Dickinson and Company (U.S.) Recent Developments
11.3 Cook Group Incorporated (U.S.)
11.3.1 Cook Group Incorporated (U.S.) Corporation Information
11.3.2 Cook Group Incorporated (U.S.) Overview
11.3.3 Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cook Group Incorporated (U.S.) Recent Developments
11.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
11.4.1 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Corporation Information
11.4.2 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Overview
11.4.3 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Recent Developments
11.5 Argon Medical Devices (U.S.)
11.5.1 Argon Medical Devices (U.S.) Corporation Information
11.5.2 Argon Medical Devices (U.S.) Overview
11.5.3 Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Argon Medical Devices (U.S.) Recent Developments
11.6 B. Braun Melsungen AG (Germany)
11.6.1 B. Braun Melsungen AG (Germany) Corporation Information
11.6.2 B. Braun Melsungen AG (Germany) Overview
11.6.3 B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 B. Braun Melsungen AG (Germany) Recent Developments
11.7 Cardinal Health, Inc. (U.S.)
11.7.1 Cardinal Health, Inc. (U.S.) Corporation Information
11.7.2 Cardinal Health, Inc. (U.S.) Overview
11.7.3 Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cardinal Health, Inc. (U.S.) Recent Developments
11.8 Olympus Corporation (Japan)
11.8.1 Olympus Corporation (Japan) Corporation Information
11.8.2 Olympus Corporation (Japan) Overview
11.8.3 Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Olympus Corporation (Japan) Recent Developments
11.9 Boston Scientific Corporation (U.S.)
11.9.1 Boston Scientific Corporation (U.S.) Corporation Information
11.9.2 Boston Scientific Corporation (U.S.) Overview
11.9.3 Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Boston Scientific Corporation (U.S.) Recent Developments
11.10 FUJIFILM Holdings Corporation (Japan)
11.10.1 FUJIFILM Holdings Corporation (Japan) Corporation Information
11.10.2 FUJIFILM Holdings Corporation (Japan) Overview
11.10.3 FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 FUJIFILM Holdings Corporation (Japan) Recent Developments
11.11 INRAD, Inc. (U.S.)
11.11.1 INRAD, Inc. (U.S.) Corporation Information
11.11.2 INRAD, Inc. (U.S.) Overview
11.11.3 INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 INRAD, Inc. (U.S.) Recent Developments
11.12 Medtronic plc (Ireland)
11.12.1 Medtronic plc (Ireland) Corporation Information
11.12.2 Medtronic plc (Ireland) Overview
11.12.3 Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Medtronic plc (Ireland) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Stereotactic-guided Biopsy Instrument Industry Chain Analysis
12.2 Stereotactic-guided Biopsy Instrument Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Stereotactic-guided Biopsy Instrument Production Mode & Process
12.4 Stereotactic-guided Biopsy Instrument Sales and Marketing
12.4.1 Stereotactic-guided Biopsy Instrument Sales Channels
12.4.2 Stereotactic-guided Biopsy Instrument Distributors
12.5 Stereotactic-guided Biopsy Instrument Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Stereotactic-guided Biopsy Instrument Industry Trends
13.2 Stereotactic-guided Biopsy Instrument Market Drivers
13.3 Stereotactic-guided Biopsy Instrument Market Challenges
13.4 Stereotactic-guided Biopsy Instrument Market Restraints
14 Key Findings in The Global Stereotactic-guided Biopsy Instrument Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Stereotactic-guided Biopsy Instrument Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Needle-based Biopsy Instruments
Table 3. Major Manufacturers of Localization Wires
Table 4. Major Manufacturers of Procedure Trays
Table 5. Major Manufacturers of Others
Table 6. Global Stereotactic-guided Biopsy Instrument Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Stereotactic-guided Biopsy Instrument Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Stereotactic-guided Biopsy Instrument Sales by Region (2017-2022) & (K Units)
Table 9. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Region (2017-2022)
Table 10. Global Stereotactic-guided Biopsy Instrument Sales by Region (2023-2028) & (K Units)
Table 11. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Region (2023-2028)
Table 12. Global Stereotactic-guided Biopsy Instrument Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Region (2017-2022)
Table 14. Global Stereotactic-guided Biopsy Instrument Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Region (2023-2028)
Table 16. Global Stereotactic-guided Biopsy Instrument Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Stereotactic-guided Biopsy Instrument Sales Share by Manufacturers (2017-2022)
Table 18. Global Stereotactic-guided Biopsy Instrument Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Stereotactic-guided Biopsy Instrument Revenue Share by Manufacturers (2017-2022)
Table 20. Stereotactic-guided Biopsy Instrument Price by Manufacturers (2017-2022) &(USD/Unit)
Table 21. Global Stereotactic-guided Biopsy Instrument Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Stereotactic-guided Biopsy Instrument by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stereotactic-guided Biopsy Instrument as of 2021)
Table 23. Stereotactic-guided Biopsy Instrument Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Stereotactic-guided Biopsy Instrument Product Offered
Table 25. Date of Manufacturers Enter into Stereotactic-guided Biopsy Instrument Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Stereotactic-guided Biopsy Instrument Sales by Type (2017-2022) & (K Units)
Table 28. Global Stereotactic-guided Biopsy Instrument Sales by Type (2023-2028) & (K Units)
Table 29. Global Stereotactic-guided Biopsy Instrument Sales Share by Type (2017-2022)
Table 30. Global Stereotactic-guided Biopsy Instrument Sales Share by Type (2023-2028)
Table 31. Global Stereotactic-guided Biopsy Instrument Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Stereotactic-guided Biopsy Instrument Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Stereotactic-guided Biopsy Instrument Revenue Share by Type (2017-2022)
Table 34. Global Stereotactic-guided Biopsy Instrument Revenue Share by Type (2023-2028)
Table 35. Stereotactic-guided Biopsy Instrument Price by Type (2017-2022) & (USD/Unit)
Table 36. Global Stereotactic-guided Biopsy Instrument Price Forecast by Type (2023-2028) & (USD/Unit)
Table 37. Global Stereotactic-guided Biopsy Instrument Sales by Application (2017-2022) & (K Units)
Table 38. Global Stereotactic-guided Biopsy Instrument Sales by Application (2023-2028) & (K Units)
Table 39. Global Stereotactic-guided Biopsy Instrument Sales Share by Application (2017-2022)
Table 40. Global Stereotactic-guided Biopsy Instrument Sales Share by Application (2023-2028)
Table 41. Global Stereotactic-guided Biopsy Instrument Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Stereotactic-guided Biopsy Instrument Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Stereotactic-guided Biopsy Instrument Revenue Share by Application (2017-2022)
Table 44. Global Stereotactic-guided Biopsy Instrument Revenue Share by Application (2023-2028)
Table 45. Stereotactic-guided Biopsy Instrument Price by Application (2017-2022) & (USD/Unit)
Table 46. Global Stereotactic-guided Biopsy Instrument Price Forecast by Application (2023-2028) & (USD/Unit)
Table 47. North America Stereotactic-guided Biopsy Instrument Sales by Type (2017-2022) & (K Units)
Table 48. North America Stereotactic-guided Biopsy Instrument Sales by Type (2023-2028) & (K Units)
Table 49. North America Stereotactic-guided Biopsy Instrument Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Stereotactic-guided Biopsy Instrument Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Stereotactic-guided Biopsy Instrument Sales by Application (2017-2022) & (K Units)
Table 52. North America Stereotactic-guided Biopsy Instrument Sales by Application (2023-2028) & (K Units)
Table 53. North America Stereotactic-guided Biopsy Instrument Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Stereotactic-guided Biopsy Instrument Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Stereotactic-guided Biopsy Instrument Sales by Country (2017-2022) & (K Units)
Table 56. North America Stereotactic-guided Biopsy Instrument Sales by Country (2023-2028) & (K Units)
Table 57. North America Stereotactic-guided Biopsy Instrument Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Stereotactic-guided Biopsy Instrument Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Stereotactic-guided Biopsy Instrument Sales by Type (2017-2022) & (K Units)
Table 60. Europe Stereotactic-guided Biopsy Instrument Sales by Type (2023-2028) & (K Units)
Table 61. Europe Stereotactic-guided Biopsy Instrument Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Stereotactic-guided Biopsy Instrument Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Stereotactic-guided Biopsy Instrument Sales by Application (2017-2022) & (K Units)
Table 64. Europe Stereotactic-guided Biopsy Instrument Sales by Application (2023-2028) & (K Units)
Table 65. Europe Stereotactic-guided Biopsy Instrument Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Stereotactic-guided Biopsy Instrument Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Stereotactic-guided Biopsy Instrument Sales by Country (2017-2022) & (K Units)
Table 68. Europe Stereotactic-guided Biopsy Instrument Sales by Country (2023-2028) & (K Units)
Table 69. Europe Stereotactic-guided Biopsy Instrument Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Stereotactic-guided Biopsy Instrument Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Stereotactic-guided Biopsy Instrument Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Stereotactic-guided Biopsy Instrument Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Stereotactic-guided Biopsy Instrument Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Stereotactic-guided Biopsy Instrument Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Stereotactic-guided Biopsy Instrument Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Stereotactic-guided Biopsy Instrument Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Stereotactic-guided Biopsy Instrument Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Stereotactic-guided Biopsy Instrument Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Stereotactic-guided Biopsy Instrument Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Stereotactic-guided Biopsy Instrument Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Stereotactic-guided Biopsy Instrument Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Stereotactic-guided Biopsy Instrument Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Stereotactic-guided Biopsy Instrument Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Stereotactic-guided Biopsy Instrument Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Stereotactic-guided Biopsy Instrument Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Stereotactic-guided Biopsy Instrument Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Stereotactic-guided Biopsy Instrument Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Stereotactic-guided Biopsy Instrument Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Stereotactic-guided Biopsy Instrument Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Stereotactic-guided Biopsy Instrument Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Stereotactic-guided Biopsy Instrument Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Stereotactic-guided Biopsy Instrument Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Stereotactic-guided Biopsy Instrument Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Stereotactic-guided Biopsy Instrument Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Stereotactic-guided Biopsy Instrument Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Stereotactic-guided Biopsy Instrument Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Stereotactic-guided Biopsy Instrument Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Stereotactic-guided Biopsy Instrument Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Stereotactic-guided Biopsy Instrument Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Stereotactic-guided Biopsy Instrument Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Stereotactic-guided Biopsy Instrument Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Stereotactic-guided Biopsy Instrument Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Stereotactic-guided Biopsy Instrument Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Stereotactic-guided Biopsy Instrument Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Stereotactic-guided Biopsy Instrument Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Stereotactic-guided Biopsy Instrument Revenue by Country (2023-2028) & (US$ Million)
Table 107. C. R. Bard, Inc. (U.S.) Corporation Information
Table 108. C. R. Bard, Inc. (U.S.) Description and Major Businesses
Table 109. C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. C. R. Bard, Inc. (U.S.) Recent Developments
Table 112. Becton, Dickinson and Company (U.S.) Corporation Information
Table 113. Becton, Dickinson and Company (U.S.) Description and Major Businesses
Table 114. Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Becton, Dickinson and Company (U.S.) Recent Developments
Table 117. Cook Group Incorporated (U.S.) Corporation Information
Table 118. Cook Group Incorporated (U.S.) Description and Major Businesses
Table 119. Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Cook Group Incorporated (U.S.) Recent Developments
Table 122. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Corporation Information
Table 123. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Description and Major Businesses
Table 124. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Recent Developments
Table 127. Argon Medical Devices (U.S.) Corporation Information
Table 128. Argon Medical Devices (U.S.) Description and Major Businesses
Table 129. Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Argon Medical Devices (U.S.) Recent Developments
Table 132. B. Braun Melsungen AG (Germany) Corporation Information
Table 133. B. Braun Melsungen AG (Germany) Description and Major Businesses
Table 134. B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. B. Braun Melsungen AG (Germany) Recent Developments
Table 137. Cardinal Health, Inc. (U.S.) Corporation Information
Table 138. Cardinal Health, Inc. (U.S.) Description and Major Businesses
Table 139. Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Cardinal Health, Inc. (U.S.) Recent Developments
Table 142. Olympus Corporation (Japan) Corporation Information
Table 143. Olympus Corporation (Japan) Description and Major Businesses
Table 144. Olympus Corporation
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs